Bioqual, Inc. (OTCMKTS:BIOQ – Get Free Report) traded down 6.2% on Thursday . The stock traded as low as $57.50 and last traded at $57.50. 500 shares traded hands during mid-day trading, an increase of 150% from the average session volume of 200 shares. The stock had previously closed at $61.30.
Bioqual Price Performance
The firm has a market capitalization of $51.41 million, a price-to-earnings ratio of -18.37 and a beta of -0.33. The business has a 50-day moving average of $60.33 and a two-hundred day moving average of $64.82.
Bioqual (OTCMKTS:BIOQ – Get Free Report) last announced its quarterly earnings data on Tuesday, January 21st. The company reported ($1.36) earnings per share for the quarter. Bioqual had a negative return on equity of 7.50% and a negative net margin of 5.54%.
About Bioqual
Bioqual, Inc provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer.
Recommended Stories
- Five stocks we like better than Bioqual
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- MarketBeat Week in Review – 03/24 – 03/28
- How to Short a Stock in 5 Easy Steps
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- 3 Warren Buffett Stocks to Buy Now
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Bioqual Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioqual and related companies with MarketBeat.com's FREE daily email newsletter.
